蛋白质稳态
生物
背景(考古学)
癌症研究
癌症
内质网相关蛋白降解
癌细胞
细胞生物学
生物标志物
细胞生长
程序性细胞死亡
脂质代谢
自噬
微泡
疾病
细胞
信号转导
氧化应激
泛素
机制(生物学)
串扰
蛋白质降解
肿瘤进展
甲状腺癌
生物信息学
细胞代谢
分子肿瘤学
小RNA
平衡
未折叠蛋白反应
恶性转化
肿瘤微环境
KEAP1型
转移
作者
Yumiao Zhen,S Z Chen,Bo Niu,Yitao Wang,Chung-Hang Leung,Hai-Jing Zhong
标识
DOI:10.1016/j.phrs.2026.108236
摘要
Malignant neoplasms are a leading cause of morbidity and mortality globally, with rising rates despite advancements in detection and treatment. This review examines the multifaceted role of MARCH6, an endoplasmic reticulum-resident E3 ubiquitin ligase, in cancer biology and disease regulation. MARCH6 exhibits a complex, context-dependent dual role: it functions as a pro-oncogenic driver in papillary thyroid carcinoma (PTC) and hepatocellular carcinoma (HCC), where it promotes cell proliferation and metastatic potential, yet simultaneously serves protective roles in non-malignant pathological conditions, including the regulation of ferroptosis, a form of iron-dependent lipid peroxidation-driven cell death, and antiviral immunity. In particular, emerging evidence suggests that MARCH6 can modulate ferroptosis through the selective degradation of key regulators such as p53 and ACSL4, thereby linking ubiquitin-mediated proteostasis to redox balance and lipid metabolism. The review synthesizes current understanding of MARCH6's structure, substrate specificity, and tissue-specific functional outcomes, emphasizing the molecular determinants of its context-dependent activity across different cellular contexts. Particular attention is given to MARCH6's regulatory impact on cholesterol and lipid metabolism, oxidative stress responses, and cell death mechanisms, with ferroptosis positioned as a central mechanistic axis through which MARCH6 may influence tumor progression and therapeutic response. Despite these mechanistic advances, critical knowledge gaps persist regarding substrate selectivity across diverse cancer types, the molecular basis of functional polarity, and therapeutic feasibility. This synthesis aims to guide future research toward harnessing MARCH6's potential as a biomarker and selective therapeutic target in cancer and stress-related diseases, particularly in the context of ferroptosis modulation, while acknowledging the inherent challenges in targeting its context-dependent functions.
科研通智能强力驱动
Strongly Powered by AbleSci AI